Results Healthcare has advised Deallus Consulting on its acquisition by ArchiMed

OVERVIEW
Deallus Consulting is a leading global life sciences consultancy. The Company helps clients improve company strategy by better understanding and preparing for market change through efficient, comprehensive and rigorous research and analysis of the competitive landscape.

Founded in London in 2004, Deallus has grown to become one of the premium life sciences strategy consultancies, working with 25 of the world’s top 30 pharmaceutical, biotechnology and vaccines companies, as well as a wide range of small and medium size life sciences companies. The Company has successfully established a global footprint, with offices in London, New York, Los Angeles, Princeton, Singapore, Tokyo and Shanghai.

Deallus is renowned for its highly qualified 60-strong consulting staff. Over 80% of consultants have earned PhDs from leading academic institutions and among them they speak 22 languages.

OPPORTUNITY
After leading the business throughout its history, by 2015 Deallus’ owners had completed a well-planned process to transition responsibility for running the business to the current senior management team, who were also among Deallus’ longest-standing employees. Having placed Deallus on a secure footing for long-term growth, the founders engaged Results to identify a long-term, supportive partner who would assist the management team in further expanding Deallus’ service offering, client reach and global footprint.

OUTCOME
Results organised a competitive process to identify the best partner for Deallus, resulting in a series of meetings between Deallus’ leadership team and a selection of international healthcare consultancies and sector-specific private equity firms. ArchiMed, a healthcare specialist European private equity firm was chosen as the best fit for Deallus.